Interleukin-2 Transcription Is Regulated In Vivo at the Level of Coordinated Binding of Both Constitutive and Regulated Factors

REFERENCES

• Brabletz, T., I. Pietrowski, and E. Serfling. 1991. The immunosuppressive FK 506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer. Nucleic Acids Res. 19:61–67.
   PubMedGoogle Scholar
• Briegel, K., B. Hentsch, I. Pfeuffer, and E. Serfling. 1991. One base pair change abolishes the T cell-restricted activity of a κB-like proto-enhancer element from the interleukin 2 promoter. Nucleic Acids Res. 19:5929–5936.
   PubMed Web of Science ®Google Scholar
• Brorson, K. A., B. Beverly, S. M. Kang, M. Lenardo, and R. H. Schwartz. 1991. Transcriptional regulation of cytokine genes in nontransformed-T cells: apparent constitutive signals in run-on assays can be caused by repeat sequences. J. Immunol. 147:3601–3609.
   PubMedGoogle Scholar
• Brunvand, M. W., A. Schmidt, and U. Siebenlist. 1988. Nuclear factors interacting with the mitogen-responsive regulatory region of the interleukin-2 gene. J. Biol. Chem. 263:18904–18910.
   PubMedGoogle Scholar
• Chen, D., and E. V. Rothenberg. 1993. Molecular basis for developmental changes in interleukin-2 gene inducibility. Mol. Cell. Biol. 13:228–237.
   PubMedGoogle Scholar
• Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156–159.
   PubMed Web of Science ®Google Scholar
• Durand, D. B., J.-P. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, and G. R. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715–1724.
   PubMed Web of Science ®Google Scholar
• Emmel, E. A., C. L. Verweij, D. B. Durand, K. M. Higgins, E. Lacy, and G. R. Crabtree. 1989. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 246:1617–1620.
   PubMed Web of Science ®Google Scholar
• Ephrussi, A., G. M. Church, S. Tonegawa, and W. Gilbert. 1985. B lineage specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227:134–140.
   PubMed Web of Science ®Google Scholar
• Flanagan, W. M., B. Corthesy, R. J. Bram, and G. R. Crabtree. 1991. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature (London) 352:803–807.
   PubMed Web of Science ®Google Scholar
• Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1992. Regulation of interleukin-2 gene enhancer activity by the T-cell accessory molecule CD28. Science 251:313–316.
   Google Scholar
• Garrity, P. A., and B. J. Wold. 1992. Effects of different DNA polymerases in ligation-mediated PCR: enhanced genomic sequencing and in vivo footprinting. Proc. Natl. Acad. Sci. USA 89:1021–1025.
   PubMedGoogle Scholar
• Gonzalez, G. A., K. K. Yamamoto, W. H. Fischer, D. Karr, P. Menzel, W. Biggs III, W. W. Vale, and M. R. Montminy. 1989. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature (London) 337:749–752.
   PubMed Web of Science ®Google Scholar
• Granelli-Piperno, A., and P. Nolan. 1991. Nuclear transcription factors that bind to elements of the IL-2 promoter. J. Immunol. 147:2734–2739.
   PubMedGoogle Scholar
• Hentsch, B., A. Mouzaki, I. Pfeuffer, D. Rungger, and E. Serfling. 1992. The weak, fine-tuned binding to ubiquitous transcription factors to the IL-2 enhancer contributes to its T cell-restricted activity. Nucleic Acids Res. 20:2657–2665.
   PubMedGoogle Scholar
• Herrera, R. E., P. E. Shaw, and A. Nordheim. 1989. Occupation of the c-fos serum response element in vivo by a multiprotein complex is unaltered by growth factor induction. Nature (London) 340:68–70.
   PubMedGoogle Scholar
• Jain, J., V. E. Valge-Archer, and A. Rao. 1992. Analysis of the AP-1 sites in the IL-2 promoter. J. Immunol. 148:1240–1250.
   PubMed Web of Science ®Google Scholar
• Kamps, M. P., L. Corcoran, J. H. LeBowitz, and D. Baltimore. 1990. The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Mol. Cell. Biol. 10:5464–5472.
   PubMedGoogle Scholar
• Kang, S. M., A. C. Tran, M. Grilli, and M. J. Lenardo. 1992. NF-κB subunit regulation in nontransformed CD4+ T-lymphocytes. Science 256:1452–1456.
   PubMed Web of Science ®Google Scholar
• Kara, C. J., and L. H. Glimcher. 1991. In vivo footprinting of MHC class II genes: bare promoters in bare lymphocyte syndrome. Science 252:709–712.
   PubMedGoogle Scholar
• Kovary, K., and R. Bravo. 1991. The Jun and Fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11:4466–4472.
   PubMed Web of Science ®Google Scholar
• Kronke, M., W. J. Leonard, J. M. Depper, and W. C. Greene. 1985. Sequential expression of genes involved in human T lymphocyte growth and differentiation. J. Exp. Med. 161:1593–1598.
   PubMedGoogle Scholar
• Mattila, P. S., K. S. Ullman, S. Fiering, E. A. Emmel, M. McCutcheon, G. R. Crabtree, and L. A. Herzenberg. 1990. The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J. 9:4425–4433.
   PubMedGoogle Scholar
• McGuire, K. L., and E. V. Rothenberg. 1987. Inducibility of interleukin-2 RNA expression in individual mature and immature T lymphocytes. EMBO J. 6:939–946.
   PubMed Web of Science ®Google Scholar
• McGuire, K. L., J. A. Yang, and E. V. Rothenberg. 1988. Influence of activating stimulus on functional phenotype: interleukin-2 mRNA accumulation differentially induced by ionophore and receptor ligands in subsets of murine T cells. Proc. Natl. Acad. Sci. USA 85:6503–6507.
   PubMed Web of Science ®Google Scholar
• Miner, J. H., and B. J. Wold. 1991. c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation. Mol. Cell. Biol. 11:2842–2851.
   PubMedGoogle Scholar
• Mueller, P. R., P. Garrity, and B. Wold. 1992. Ligation-mediated single-sided PCR for genomic sequencing and footprinting, p. 15.5.1–15.5.26. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. John Wiley & Sons, New York.
   Google Scholar
• Mueller, P. R., S. J. Salser, and B. Wold. 1988. Constitutive and metal-inducible protein:DNA interactions at the mouse metallo-thionein-I promoter examined by in vivo and in vitro footprinting. Genes Dev. 2:412–427.
   PubMedGoogle Scholar
• Mueller, P. R., and B. Wold. 1989. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246:780–786.
   PubMed Web of Science ®Google Scholar
• Novak, T. J., D. Chen, and E. V. Rothenberg. 1990. Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: molecular basis of costimulation. Mol. Cell. Biol. 10:6325–6334.
   PubMedGoogle Scholar
• Novak, T. J., and E. V. Rothenberg. 1990. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. Sci. USA 87:9353–9357.
   PubMed Web of Science ®Google Scholar
• Novak, T. J., P. M. White, and E. V. Rothenberg. 1990. Regulatory anatomy of the murine interleukin-2 gene. Nucleic Acids Res. 18:4523–4533.
   PubMed Web of Science ®Google Scholar
• Randak, C., T. Brabletz, M. Hergenrother, I. Sobotta, and E. Serfling. 1990. Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer. EMBO J. 9:2529–2536.
   PubMed Web of Science ®Google Scholar
• Rigaud, G., J. Roux, R. Pictet, and T. Grange. 1991. In vivo footprinting of rat TAT gene: dynamic interplay between the glucocorticoid receptor and a liver-specific factor. Cell 67:977–986.
   PubMed Web of Science ®Google Scholar
• Roeder, R. G. 1991. The complexities of eukaryotic transcription initiation: regulation of preinitiation complex assembly. Trends Biochem. Sci. 16:402–408.
   PubMedGoogle Scholar
• Rothenberg, E. V. 1992. The development of functionally responsive T cells. Adv. Immunol. 51:85–214.
   PubMedGoogle Scholar
• Serfling, E., R. Barthelmas, I. Pfeuffer, B. Schenk, S. Zarius, R. Swoboda, F. Mercurio, and M. Karin. 1989. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin-2 gene in T lymphocytes. EMBO J. 8:465–473.
   PubMed Web of Science ®Google Scholar
• Shaw, J.-P., K. Meerovitch, R. C. Bleackley, and V. Paetkau. 1988. Mechanisms regulating the level of IL-2 mRNA in T lymphocytes. J. Immunol. 140:2243–2248.
   PubMed Web of Science ®Google Scholar
• Shaw, J.-P., P. J. Utz, D. B. Durand, J. J. Toole, E. A. Emmel, and G. R. Crabtree. 1988. Identification of a putative regulator of early T cell activation genes. Science 241:202–205.
   PubMed Web of Science ®Google Scholar
• Stein, B., H. J. Rahmsdorf, A. Steffen, M. Litfin, and P. Herrlich. 1989. UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol. Cell. Biol. 9:5169–5181.
   PubMed Web of Science ®Google Scholar
• Tavtigian, S. V. 1992. Thesis. California Institute of Technology, Pasadena.
   Google Scholar
• Thompson, C. B., C.-Y. Wang, I.-C. Ho, P. R. Bohjanen, B. Petryniak, C. H. June, S. Miesfeldt, L. Zhang, G. J. Nabel, B. Karpinski, and J. M. Leiden. 1992. cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. Mol. Cell. Biol. 12:1043–1053.
   PubMedGoogle Scholar
• Travis, A., A. Amsterdam, C. Belanger, and R. Grosschedl. 1991. LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor a enhancer function. Genes Dev. 5:880–894.
   PubMed Web of Science ®Google Scholar
• Ullman, K. S., W. M. Flanagan, C. A. Edwards, and G. R. Crabtree. 1991. Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40. Science 254:558–562.
   PubMedGoogle Scholar
• Ullman, K. S., J. P. Northrop, C. L. Verweij, and G. R. Crabtree. 1990. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu. Rev. Immunol. 8:421–452.
   PubMed Web of Science ®Google Scholar
• van de Wetering, M., M. Oosterwegel, D. Dooijes, and H. Clevers. 1991. Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. EMBO J. 10:123–132.
   PubMed Web of Science ®Google Scholar
• Verweij, C. L., C. Guidos, and G. R. Crabtree. 1990. Cell type specificity and activation requirements for NFAT-1 (nuclear factors of activated T-cells) transcriptional activity determined by a new method using transgenic mice to assay transcriptional activity of an individual nuclear factor. J. Biol. Chem. 265:15788–15795.
   PubMedGoogle Scholar
• Waterman, M. L., W. H. Fischer, and K. A. Jones. 1991. A thymus-specific member of the HMG protein family regulates the human T cell receptor Cα enhancer. Genes Dev. 5:656–669.
   PubMed Web of Science ®Google Scholar
• Weiss, A., I. Imboden, K. Hardy, B. Manger, C. Terhorst, and J. Stobo. 1986. The role of the T3/antigen receptor complex in T-cell activation. Annu. Rev. Immunol. 4:593–619.
   PubMed Web of Science ®Google Scholar
• Williams, T. M., D. Moolten, J. Burlein, J. Romano, R. Bhaerman, A. Godillot, M. Mellon, F. J. Rauscher III, and J. A. Kant. 1991. Identification of a zinc finger protein that inhibits IL-2 gene expression. Science 254:1791–1794.
   PubMedGoogle Scholar